EyePoint Pharmaceuticals Inc.

NASDAQ: EYPT
Share price (12/20/24): $7.10
Market cap (12/20/24): $485 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Cormorant Asset Management, LP

Price T Rowe Associates Inc

Vanguard Group Inc

Adage Capital Management, L.P.

News Filter

Announces First Patient Dosed in Second Global Phase 3 LUCIA Clinical Trial of DURAVYUTM for the Treatment of Wet Age-Related Macular Degeneration

Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments

Announces Proposed Public Offering of Common Stock

Announces Positive Interim 16-Week Data for Ongoing Phase 2 VERONA Clinical Trial of DURAVYUTM for Diabetic Macular Edema

Announces First Patient Dosed in Global Phase 3 LUGANO Clinical Trial of DURAVYUTM for the Treatment of Wet Age-Related Macular Degeneration

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC